NPAT halved and $204.8m cash pile turned to net debt on 8x capex surge

What changed

Revenue grew 8.8% to $173.6m, but every profit line moved sharply the other way. EBITDA fell 34.3% to $29.5m, PBT fell 38.4% to $27.5m, and NPAT fell 50.3% to $15.7m. The effective tax rate jumped to 42.7% from 29.0%, meaning tax was a meaningful additional drag on the bottom line; on a cleaner operating read, PBT is down 38.4%.

The balance-sheet picture shifted more than the P&L. Cash fell from $204.8m to $41.7m, gross borrowings moved from nil to $64.8m (MMLIC facility), and net debt swung to roughly $23.1m from a $204.8m net cash position. Inventories rose 36.0% to $247.3m, lifting inventory days to about 520 from 416. Operating cash flow recovered to $14.2m from a $8.9m outflow, but capex of $60.5m (vs $7.2m prior) drove pre-lease free cash flow to a $46.3m outflow. The declared final dividend was cut to 0.55 cps from 1.07 cps.

What matters

• Margin compression is real, not optical. Revenue grew while EBITDA fell by $15.4m, so the decline is an operating-mix and cost issue, not a timing story. Segment disclosure shows why: residential development (93.6% of revenue) earned roughly a 27% EBIT margin, but the commercial portfolio lost $10.7m on $11.0m of revenue and retirement villages lost $2.6m. Non-core segments are materially diluting group profitability.
• Capital intensity stepped up sharply. Capex rose to 34.9% of revenue from 4.5%, and inventories increased $65.4m. The group has reallocated roughly $163m of cash into work-in-progress and fixed investment. That is consistent with the stated pre-sale settlement pipeline but converts a fortress balance sheet into a modestly levered one (net debt/EBITDA ~0.8x) in a single year.
• Dividend signalling. The 48.6% cut in the final dividend, alongside negative pre-lease FCF, suggests the board is preserving cash to fund the development pipeline rather than returning it.

Expectations

No forward targets or pre-sale book figures are disclosed in the supplied extracts, so there is no quantitative guidance anchor against which to benchmark the result. On shape, HY24 already captured 61.8% of full-year NPAT, implying H2 NPAT of about $6.0m versus $9.7m in H1 — profitability softened into the second half even as settlements (187 vs 158 units) were higher. Revenue and EBITDA were roughly evenly split, so the H2 NPAT shortfall points to mix or cost pressure rather than volume.

Quality of result

Mixed-to-low quality. The operating cash flow recovery to $14.2m looks better than it is: H2 operating cash flow was a $3.2m outflow against a $17.4m H1 inflow, consistent with heavy inventory absorption. Cash conversion at 48.1% of EBITDA is weak for a result already inflated by any non-cash fair-value movements typical of property developers (EBITDA reconciliation detail is not supplied). With pre-lease FCF at –$46.3m and capex running 8x prior, a large portion of reported profit was effectively reinvested rather than realised in cash. Nothing in the disclosures flags a one-off or a discontinued operation — the NPAT decline reflects underlying trading plus a materially higher tax rate, not a clean-up item.

Unresolved

• What drove the effective tax rate to 42.7%, and is it structural or a one-year distortion?
• What is the current pre-sales book (the prior release cited $662.2m at June 2022) and how does it underwrite the $247.3m inventory balance?
• How far through the capex cycle is the commercial portfolio, and when does it turn profitable given the ~$10.7m segment loss on $11.0m of revenue?
• What are the drawn-facility covenants and headroom on the new MMLIC facility, and is further debt likely if capex stays elevated?
• Is the retirement villages segment at pre-revenue build stage, and what is the expected unit cadence?

This briefing cannot assess whether the reported residential margins are sustainable through settlement cycles, because no gross margin, pre-sales book, or forward-work disclosure was provided in the supplied data.

Key metrics

Segment breakdown

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.